Dr. Charles Flexner, M.D

NPI: 1972546828
Total Payments
$176,847
2024 Payments
$5,470
Companies
9
Transactions
175

Payment Breakdown by Category

Consulting$143,092 (80.9%)
Travel$29,681 (16.8%)
Food & Beverage$4,074 (2.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $143,092 35 80.9%
Travel and Lodging $29,681 61 16.8%
Food and Beverage $4,074 79 2.3%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme LLC $111,989 134 $0 (2022)
ViiV Healthcare Company $37,891 14 $0 (2023)
Theratechnologies Inc. $7,899 8 $0 (2024)
GlaxoSmithKline, LLC. $4,600 1 $0 (2017)
Gilead Sciences, Inc. $3,773 13 $0 (2024)
Janssen Research & Development, LLC $3,720 1 $0 (2021)
Shionogi Inc $2,600 2 $0 (2023)
Mylan Inc. $2,255 1 $0 (2018)
CIPLA USA INC. $2,120 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,470 7 Theratechnologies Inc. ($5,399)
2023 $12,827 8 ViiV Healthcare Company ($7,475)
2022 $28,640 19 ViiV Healthcare Company ($17,540)
2021 $16,095 6 Merck Sharp & Dohme Corporation ($5,525)
2020 $2,550 1 Merck Sharp & Dohme Corporation ($2,550)
2019 $45,621 52 Merck Sharp & Dohme Corporation ($37,707)
2018 $46,305 43 Merck Sharp & Dohme Corporation ($41,903)
2017 $19,338 39 Merck Sharp & Dohme Corporation ($14,738)

All Payment Transactions

175 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
11/15/2024 Theratechnologies Inc. TROGARZO (Drug) Travel and Lodging In-kind items and services $1,072.43 General
Category: HIV
11/15/2024 Theratechnologies Inc. TROGARZO (Drug) Food and Beverage In-kind items and services $28.47 General
Category: HIV
11/01/2024 Theratechnologies Inc. TROGARZO (Drug) Consulting Fee Cash or cash equivalent $3,000.00 General
Category: HIV
10/16/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $70.99 General
10/11/2024 Theratechnologies Inc. EGRIFTA (Drug), TROGARZO Food and Beverage In-kind items and services $142.43 General
Category: HIV
08/14/2024 Theratechnologies Inc. EGRIFTA (Drug), TROGARZO Travel and Lodging In-kind items and services $577.92 General
Category: HIV
08/14/2024 Theratechnologies Inc. TROGARZO (Drug) Travel and Lodging In-kind items and services $577.92 General
Category: HIV
12/03/2023 ViiV Healthcare Company Consulting Fee Cash or cash equivalent $7,474.99 General
07/06/2023 Theratechnologies Inc. TROGARZO (Drug) Consulting Fee Cash or cash equivalent $625.00 General
Category: HIV
05/12/2023 Shionogi Inc Consulting Fee Cash or cash equivalent $2,250.00 General
05/12/2023 Shionogi Inc Travel and Lodging Cash or cash equivalent $350.00 General
05/08/2023 Gilead Sciences, Inc. Descovy (Drug) Food and Beverage In-kind items and services $64.22 General
Category: HIV
05/03/2023 Gilead Sciences, Inc. Descovy (Drug) Food and Beverage In-kind items and services $78.87 General
Category: HIV
05/01/2023 Gilead Sciences, Inc. Descovy (Drug) Food and Beverage In-kind items and services $109.00 General
Category: HIV
03/03/2023 Theratechnologies Inc. TROGARZO (Drug) Consulting Fee Cash or cash equivalent $1,875.00 General
Category: HIV
11/29/2022 ViiV Healthcare Company Consulting Fee Cash or cash equivalent $6,500.00 General
10/17/2022 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $5,115.00 General
10/17/2022 Merck Sharp & Dohme LLC Travel and Lodging Cash or cash equivalent $150.00 General
10/03/2022 Merck Sharp & Dohme LLC Travel and Lodging In-kind items and services $170.59 General
10/03/2022 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $65.00 General
10/03/2022 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $59.99 General
10/03/2022 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $44.90 General
10/02/2022 Merck Sharp & Dohme LLC Travel and Lodging In-kind items and services $229.00 General
10/02/2022 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $125.00 General
10/02/2022 Merck Sharp & Dohme LLC Travel and Lodging In-kind items and services $119.00 General

About Dr. Charles Flexner, M.D

Dr. Charles Flexner, M.D is a Infectious Disease healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972546828.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Flexner, M.D has received a total of $176,847 in payments from pharmaceutical and medical device companies, with $5,470 received in 2024. These payments were reported across 175 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($143,092).

Practice Information

  • Specialty Infectious Disease
  • Other Specialties Internal Medicine
  • Location Baltimore, MD
  • Active Since 06/14/2006
  • Last Updated 06/07/2010
  • Taxonomy Code 207RI0200X
  • Entity Type Individual
  • NPI Number 1972546828

Products in Payments

  • DELSTRIGO (Drug) $26,100
  • TROGARZO (Drug) $7,179
  • Symfi Lo (Drug) $2,255
  • Biktarvy (Drug) $1,790
  • EGRIFTA (Drug) $720.35
  • MK-8591 (Drug) $417.41
  • Descovy (Drug) $252.09
  • Viread (Drug) $97.63
  • ISENTRESS (Drug) $20.49

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Infectious Disease Doctors in Baltimore